Teva CEO says manufacturing cuts will keep coming even after $3B reduction achieved | FiercePharma
Teva halts production at sterile injectables plant to address FDA concerns | FiercePharma
Teva, the world's largest generic drugmaker, is cutting 14,000 workers - Los Angeles Times
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Teva makes first foray into medical cannabis sector, with new distribution deal | The Times of Israel
Teva Pharmaceuticals - Wikipedia
Taiyo Pharmaceutical Industry, Contract Manufacturing Plant - Pharmaceutical Technology
There May Be a Silver Lining to Teva's Woes | Ctech
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines | Fortune
Teva to cut 14,000 jobs | Business | Chemistry World
Teva Recalls U.S.-Made Drugs Following Contamination Fears - Bloomberg
Teva Pharmaceuticals - Wikipedia
Teva plans the large-scale production of monoclonal antibodies in Ulm - Healthcare industry
Award of Merit Manufacturing: TEVA Biologics Manufacturing Facility | 2018-10-16 | Engineering News-Record
Drugmaker to pay $1.2 billion to settle 'pay for delay' lawsuit | PBS NewsHour
Teva looks to plug gap in its biomanufacturing network
Teva plans 'risky' price rise on US medicines | Financial Times
Teva says it's in talks with COVID vaccine makers to help produce shots | The Times of Israel
Anything but Generic: A map for Selling to Teva Pharmaceuticals
Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
Drugmaker Teva makes $40B bid for rival Mylan
Teva Pharmaceuticals to slash 14,000 jobs and suspend its dividend
